ACUT: AccuStem Sciences, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 4.77
Enterprise Value ($M) 4.79
Book Value ($M) -3.19
Book Value / Share -0.28
Price / Book -1.49
NCAV ($M) -3.19
NCAV / Share -0.28
Price / NCAV -1.49

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -10.30
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.03
Current Ratio 0.03

Balance Sheet (mrq) ($M)
Current Assets 0.10
Assets 0.10
Liabilities 3.30
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)
Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-18 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-09-16 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-05-20 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-03-22 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTI

(click for more detail)

Similar Companies
ABMC – American Bio Medica Corporation ABTI – Alterola Biotech, Inc.
ACUR – Acura Pharmaceuticals, Inc. ADIA – Adia Nutrition, Inc.
ADXS – Ayala Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io